PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects

التفاصيل البيبلوغرافية
العنوان: PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects
المؤلفون: Nalinee Chongjaroen, Pa-thai Yenchitsomanus, Kanjana Chanprasert, Suwattanee Kooptiwut, Watip Tangjittipokin, Namoiy Semprasert, Jatuporn Sujjitjoon, Wanthanee Hanchang, Nattachet Plengvidhya
المصدر: Journal of Human Genetics. 61:943-949
بيانات النشر: Springer Science and Business Media LLC, 2016.
سنة النشر: 2016
مصطلحات موضوعية: Blood Glucose, Male, 0301 basic medicine, Linkage disequilibrium, medicine.medical_treatment, Gene Expression, Type 2 diabetes, Mice, 0302 clinical medicine, Gene Frequency, Insulin-Secreting Cells, Genotype, Odds Ratio, Insulin, Paired Box Transcription Factors, Promoter Regions, Genetic, Genetics (clinical), Genetics, Exons, Immunohistochemistry, Protein Transport, Female, Transcriptional Activation, medicine.medical_specialty, Cell Survival, 030209 endocrinology & metabolism, Biology, Glucagon, Cell Line, 03 medical and health sciences, Stress, Physiological, Internal medicine, medicine, Animals, Humans, RNA, Messenger, Codon, Allele frequency, Alleles, Genetic Association Studies, Homeodomain Proteins, Polymorphism, Genetic, Haplotype, Promoter, medicine.disease, 030104 developmental biology, Endocrinology, Amino Acid Substitution, Diabetes Mellitus, Type 2, Case-Control Studies
الوصف: We have previously identified PAX4 mutations causing MODY9 and a recent genome-wide association study reported a susceptibility locus of type 2 diabetes (T2D) near PAX4. In this study, we aim to investigate the association between PAX4 polymorphisms and T2D in Thai patients and examine functions of PAX4 variant proteins. PAX4 rs2233580 (R192H) and rs712701 (P321H) were genotyped in 746 patients with T2D and 562 healthy normal control subjects by PCR and restriction-fragment length polymorphism method. PAX4 variant proteins were investigated for repressor function on human insulin and glucagon promoters and for cell viability and apoptosis upon high glucose exposure. Genotype and allele frequencies of PAX4 rs2233580 were more frequent in patients with T2D than in control subjects (P=0.001 and 0.0006, respectively) with odds ratio of 1.66 (P=0.001; 95% confidence interval, 1.22-2.27). PAX4 rs712701 was not associated with T2D but it was in linkage disequilibrium with rs2233580. The 192H/321H (A/A) haplotype was more frequent in T2D patients than in controls (9.5% vs 6.6%; P=0.009). PAX4 R192H, but not PAX4 P321H, impaired repression activities on insulin and glucagon promoters and decreased transcript levels of genes required to maintain β-cell function, proliferation and survival. Viability of β-cell was reduced under glucotoxic stress condition for the cells overexpressing either PAX4 R192H or PAX4 P321H or both. Thus these PAX4 polymorphisms may increase T2D risk by defective transcription regulation of target genes and/or decreased β-cell survival in high glucose condition.
تدمد: 1435-232X
1434-5161
DOI: 10.1038/jhg.2016.80
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a4745afacf279b0529ffc6087598df
https://doi.org/10.1038/jhg.2016.80
Rights: CLOSED
رقم الانضمام: edsair.doi.dedup.....26a4745afacf279b0529ffc6087598df
قاعدة البيانات: OpenAIRE
الوصف
تدمد:1435232X
14345161
DOI:10.1038/jhg.2016.80